Indeed, IGF-1R is the most targted molecule in IGFs pathways that was tested with several different approaches in cancer.105 Although mAb against IGF-1R have shown single-agent activity, their combination with other therapies has not been promising (Table 1). Here, IGF1R is linked to cancer.